MDM2 Promoter Del1518 Polymorphism and Cancer Risk: Evidence From 22,931 Subjects

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s140424
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy